Global biopharmaceutical company that develops and manufactures biosimilars.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | CGCN GROUP, LLC |
3rd Quarter (July 1 - Sep 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| CGCN GROUP, LLC | 1 | — |
| Issue | Activities |
|---|---|
| Manufacturing | 1 |
| Health Issues | 1 |
| Tariff (miscellaneous tariff bills) | 1 |